Delivery Order SPE2DB24D8001-SPE2DB25FKZHB
Award Date
2/27/25
Potential Completion Date
2/28/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a ceiling value of $12,238.31 and a period of performance through November 22, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) awarded to Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 4566211938 NURTEC ODT 75 MG TABLET 8S. The delivery order, valued at $11,724.07, is for a firm fixed price contract with an ultimate completion date of October 28, 2024. The contract is not set aside and is part of DLA's ECAT Generation V Program, a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that enables Dakota Drug,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $15,803.27, is for the delivery of NURTEC ODT 75 MG TABLET 8S. This order is placed under Dakota Drug's existing Indefinite Delivery Contract (IDC) SPE2DB24D8001 with the DLA, which has a ceiling value of $999,999,999.00. The IDC allows Dakota Drug to provide a range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $5,399.31, is for the delivery of NURTEC ODT 75 MG TABLET 8S pharmaceutical products. The contract is a firm-fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA Troop Support Medical's ECAT Generation V...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, with a ceiling value of $4,121.49, is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The award is not associated with a larger contract vehicle and does not have a set-aside designation. The contract has an ultimate completion date of January 26, 2024. Dakota Drug, Inc. is a key supplier...
This federal contract award, with ID SPE2DB24D8001|SPE2DB25FKZHJ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,020.34 firm fixed-price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a performance period through March 4, 2025. The contract is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,506.31 firm fixed-price delivery order is for the provision of NURTEC ODT 75 MG TABLET 8S, a prescription medication. The award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a wide range of pharmaceutical products,...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $3,749.33, to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of NURTEC ODT 75 MG TABLET 8S. This contract, identified as SPE2DX15D8001|SPE2DX24FBQHH, has an ultimate completion date of January 23, 2024. The contract is not designated as a set-aside and was awarded directly to Dakota Drug, Inc. without a prime contractor. Dakota Drug,...
The Defense Logistics Agency (DLA) awarded a $6,555.86 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, identified as SPE2DB24D8003, is for the delivery of 4565860418 NURTEC ODT 75 MG TABLET 8S pharmaceutical products. This delivery order is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,362.08 firm fixed-price delivery order is for the provision of NURTEC ODT 75 MG tablets. This contract falls under DLA's ECAT Generation V Program, which aims to procure commercial medical equipment, accessories, consumables, and medical simulation equipment from manufacturers and distributors. Dakota Drug, Inc. holds a...